United Therapeutics Corp. Submits SEC Filing for Form 8-K

Strategic Insights -

United Therapeutics Corp. recently posted a U.S. Securities and Exchange Commission (SEC) filing for Form 8-K on December 17, 2014. The filing, which can be accessed through the SEC's website, reveals important information about the company's corporate changes and material events. As a biotechnology company specializing in pharmaceutical preparations, United Therapeutics Corp. is required to submit periodic filings with the SEC to keep investors and security holders informed.

Key Takeaways:

  • The SEC filing, which is designated as Form 8-K, is a "current report" that provides information on material events or corporate changes that have not been previously reported by the company.
  • The filing was made by United Therapeutics Corp. on December 17, 2014, and can be accessed through the SEC's website, specifically through the EDGAR database.
  • The filing includes information on the company's SIC code, which is 2834, and provides contact details for the company, including its address and phone number.
  • The filing is part of the company's ongoing efforts to comply with SEC regulations and maintain transparency with investors.
  • The company's SEC filing is available for public access on the SEC's website, providing a valuable resource for investors and industry analysts.

Statistics:

  • The SEC filing was made on December 17, 2014.
  • The filing includes information on the company's SIC code, which is 2834.
  • The company's contact information is as follows: 1040 SPRING ST, SILVER SPRING MD 20910, 3016089292.
  • The filing includes 7 documents submitted by the company.
  • The SEC file number for this filing is 0001104659-14-087170.

Sources:

  • United States Securities and Exchange Commission (SEC). September 15, 2009. Form 8-K: What Do You Need to Know?
  • United States Securities and Exchange Commission (SEC). 2014. EDGAR Database.
  • United Therapeutics Corp. December 17, 2014. Form 8-K SEC Filing.